Skip to content
drillr.ai
Sign up

CTOR

Citius Oncology, Inc.

NASDAQ · Healthcare · Drug Manufacturers - General · US

$0.86
+8.56%
Ask drillr

  • Aug 14, 2026, 00:00 UTC

    Citius Oncology, Inc. reported its Q3 2026 financial results, with revenue of $1.5 million and a net loss of $8.9 million.